This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
Adverse effects of statin therapy

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

A joint consensus statement from the European Society of Cardiology and the European Atherosclerosis Society Task Force.

Publication in full


François Mach*, Kausik K. Ray, Olov Wiklund, Alberto Corsini, Alberico L. Catapano, Eric Bruckert, Guy De Backer, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Ronald M. Krauss, Ulrich Laufs, Lawrence A. Leiter, Winfried März, Børge G. Nordestgaard, Frederick J. Raal, Michael Roden, Raul D. Santos, Evan A. Stein, Erik S. Stroes, Paul D. Thompson, Lale Tokgözoglu, Georgirene D. Vladutiu, Baris Gencer, Jane K. Stock, Henry N. Ginsberg, and M. John Chapman; European Atherosclerosis Society Consensus Panel.


EAS Consensus panel answers the questions on statin safety, by Jane K. Stock

Slide set


Membership Software Powered by YourMembership  ::  Legal